// App-Quantinova.ai

e15094 : Molecular subtyping of colon cancer (CC) based on mutational status of RAS, BRAF, and DNA mismatch repair (MMR) proteins. Prognostic value.

Researchers

Presenter

  • Gil Raga Mireia

Principal Investigators

  • Sandra Gallach

  • Eloisa Jantus-Lewintre

  • Maria Jose Safont

  • Garcia Martinez Maria Luisa

  • Javier Garde-Noguera

  • Ruiz Carmona Maria Dolores

  • Sara Blasco

  • Vicent Giner-Bosch

  • Carlos Camps

Medical Centers

  • Hospital de Sagunto, Valencia, Spain

  • Fundacion para la Investigacion del Hospital General Universitario de Valencia, Valencia, Spain

  • Molecular Oncology Laboratory, Fundacion para la Investigacion del Hospital General Universitario de Valencia / Department of Biotechnology, Universitat Politecnica de Valencia, Valencia, Spain

  • Hospital General de Valencia, Valencia, Spain

  • Study Coordinator in CLinical Trials. Sagunto Hospital, Valencia, Spain

  • Hospital Arnau Vilanova, Valencia, Spain

  • Surgery Department. Sagunto Hospital, Valencia, Spain

  • Hospital de Sagunto, Valencia, Spain

  • Centre for Quality and Change Management, Universitat Politecnica de Valencia, Valencia, Spain

  • Consorcio Hospital General Universitario de Valencia / Department of Medicine, Universitat de Valencia, Valencia, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • MutL Homolog 1

  • MutS protein homolog 2

  • B-Raf proto-oncogene, serine/threonine kinase

  • Cluster of Differentiation 206

  • GTPase Nras

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved